Stay updated on Nivolumab and Relatlimab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The study record adds posted results and a new Phase II description with expanded endpoints and timing for efficacy measurements (e.g., ORR, PFS, PD-1/LAG-3 expression, and tumor assessments).
    Difference
    9%
    Check dated 2026-09-01T17:58:52.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The related topics section now lists Melanoma and MedlinePlus Genetics. This is a navigational/content enhancement that helps users connect the study with its disease context and genetics resources without changing any trial data.
    Difference
    0.2%
    Check dated 2026-08-25T16:37:48.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The revision tag on the page updated from v3.6.4 to v3.6.5. This reflects a new version of the page in the revision history.
    Difference
    0.1%
    Check dated 2026-08-11T08:23:00.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    A new Revision: v3.6.4 tag has been added. The previous Revision: v3.6.3 tag, along with certain related topics text (Melanoma, MedlinePlus Genetics), was removed.
    Difference
    0.2%
    Check dated 2026-07-28T03:26:16.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Metadata and related topics were updated, and the revision tag was changed from v3.6.2 to v3.6.3. These changes adjust navigation and context without altering the study details.
    Difference
    0.2%
    Check dated 2026-07-06T18:21:31.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.0 to v3.6.2 to reflect a new build. This update records the updated software version without changing the page’s content or functionality.
    Difference
    0.1%
    Check dated 2026-06-29T14:35:47.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in Melanoma Clinical Trial page.